ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ORGS Orgenesis Inc (QX)

3.37
-0.12 (-3.44%)
28 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Orgenesis Inc (QX) USOTC:ORGS OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.12 -3.44% 3.37 3.00 3.97 4.00 3.0132 3.48 6,613 20:26:36

- Current report filing (8-K)

09/10/2012 5:57pm

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) October 5, 2012
 
ORGENESIS INC.
(Exact name of registrant as specified in its charter)

Nevada 000-54329 980583166
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

21 Sparrow Circle, White Plains, NY 10605
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code: +972.4.824.2051
 
N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))



Item 1.02 Termination of a Material Definitive Agreement

Effective October 5, 2012, we terminated the letter agreement dated May 2, 2012 with the Investor Relations Group Inc.

A copy of the termination letter is attached as exhibit 10.1 to this current report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.
   
(d) Exhibits.
   
Exhibit Description
   
10.1 Termination Letter to Investor Relations Group Inc. dated October 5, 2012

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ORGENESIS INC.
 
By: /s/ Jacob Ben Arie
 
Jacob Ben Arie
Chief Executive Officer and President
 
October 5, 2012


1 Year Orgenesis (QX) Chart

1 Year Orgenesis (QX) Chart

1 Month Orgenesis (QX) Chart

1 Month Orgenesis (QX) Chart

Your Recent History

Delayed Upgrade Clock